Publication Author: Zeliadt_Steven

• Cost-effectiveness of prostate cancer chemoprevention among high-risk men.

  Zeliadt SB, Ramsey SD. Cost-effectiveness of prostate cancer chemoprevention among high-risk men. Expert Rev Pharmacoecon Outcomes Res. 2010 Oct;10(5):505-8.

  rakerr2

  October 1, 2010

• Patient recruitment methods to evaluate treatment decision making for localized prostate cancer.

  Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL. Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. Am J Clin Oncol. 2010 Aug;33(4):381-6.

  rakerr2

  August 1, 2010

• The cautionary tale of PSA testing.

  Hoffman RM, Zeliadt SB. The cautionary tale of PSA testing. Arch Intern Med. 2010 Jul 26;170(14):1262-3.

  rakerr2

  July 26, 2010

• Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey.

  Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol. 20

  rakerr2

  July 1, 2010

• Preliminary treatment considerations among men with newly diagnosed prostate cancer.

  Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care. 2010 May 1;16(5):e121-30.

  rakerr2

  May 1, 2010

• Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer.

  Ramsey SD, Zeliadt SB, Richardson LC, Pollack LA, Linden H, Blough DK, Cheteri MK, Tock L, Nagy K, Anderson N. Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer. Breast J. 2010 Jan-Feb;16(1):2

  rakerr2

  January 1, 2010

• Access to information sources and treatment considerations among men with local stage prostate cancer.

  Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF. Access to information sources and treatment considerations among men with local stage prostate cancer. Urology. 2009 Sep;74(3):509-15. Epub

  rakerr2

  September 1, 2009

• Development and validation of the mindful eating questionnaire.

  Framson C, Kristal AR, Schenk JM, Littman AJ, Zeliadt S, Benitez D. Development and validation of the mindful eating questionnaire. J Am Diet Assoc. 2009 Aug;109(8):1439-44.

  rakerr2

  August 1, 2009

• Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States.

  Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):808-15. Epub 2009 Mar 3.

  rakerr2

  March 1, 2009

• Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients.

  Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Blough DK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF. Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. Patient. 2008 Jul 1;1(3):189.

  rakerr2

  July 1, 2008